View of Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis

Return to Article Details Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis Download Download PDF